Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH ORCHID PHARMA PANACEA BIOTECH/
ORCHID PHARMA
 
P/E (TTM) x -60.9 41.8 - View Chart
P/BV x 0.9 7.7 11.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PANACEA BIOTECH   ORCHID PHARMA
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
ORCHID PHARMA
Mar-23
PANACEA BIOTECH/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs191439 43.6%   
Low Rs107273 39.2%   
Sales per share (Unadj.) Rs75.1163.1 46.0%  
Earnings per share (Unadj.) Rs-5.513.5 -40.7%  
Cash flow per share (Unadj.) Rs0.927.0 3.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs137.7168.7 81.6%  
Shares outstanding (eoy) m61.2540.82 150.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.2 91.1%   
Avg P/E ratio x-27.126.3 -103.1%  
P/CF ratio (eoy) x170.013.2 1,287.9%  
Price / Book Value ratio x1.12.1 51.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m9,14214,522 62.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,265654 193.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,5996,659 69.1%  
Other income Rs m517194 265.9%   
Total revenues Rs m5,1166,853 74.7%   
Gross profit Rs m471,235 3.8%  
Depreciation Rs m391548 71.4%   
Interest Rs m44329 13.5%   
Profit before tax Rs m128552 23.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4660-   
Profit after tax Rs m-337552 -61.1%  
Gross profit margin %1.018.5 5.5%  
Effective tax rate %363.50-   
Net profit margin %-7.38.3 -88.4%  
BALANCE SHEET DATA
Current assets Rs m5,6235,010 112.2%   
Current liabilities Rs m3,2973,719 88.7%   
Net working cap to sales %50.619.4 260.8%  
Current ratio x1.71.3 126.6%  
Inventory Days Days5957 102.4%  
Debtors Days Days481,180 4.0%  
Net fixed assets Rs m7,0287,242 97.1%   
Share capital Rs m61408 15.0%   
"Free" reserves Rs m8,3756,478 129.3%   
Net worth Rs m8,4366,886 122.5%   
Long term debt Rs m2021,488 13.5%   
Total assets Rs m12,71212,252 103.8%  
Interest coverage x3.92.7 145.0%   
Debt to equity ratio x00.2 11.1%  
Sales to assets ratio x0.40.5 66.6%   
Return on assets %-2.37.2 -32.0%  
Return on equity %-4.08.0 -49.9%  
Return on capital %2.010.5 19.0%  
Exports to sales %43.381.9 52.9%   
Imports to sales %24.437.6 65.0%   
Exports (fob) Rs m1,9925,452 36.5%   
Imports (cif) Rs m1,1242,501 44.9%   
Fx inflow Rs m1,9925,452 36.5%   
Fx outflow Rs m1,1912,726 43.7%   
Net fx Rs m8012,726 29.4%   
CASH FLOW
From Operations Rs m-4,225183 -2,303.7%  
From Investments Rs m4,303-312 -1,378.6%  
From Financial Activity Rs m-184312 -59.0%  
Net Cashflow Rs m-105183 -57.4%  

Share Holding

Indian Promoters % 73.6 69.8 105.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 18.6 5.1%  
FIIs % 0.3 4.1 6.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 30.2 87.6%  
Shareholders   47,091 36,931 127.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs Orchid Pharma Share Price Performance

Period Panacea Biotech Orchid Pharma S&P BSE HEALTHCARE
1-Day -1.74% -0.40% 1.18%
1-Month -20.01% -14.06% -0.75%
1-Year 11.75% 173.54% 61.82%
3-Year CAGR -12.26% -23.64% 18.16%
5-Year CAGR -9.98% 184.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.